Evidence map›Paper›PMID 23664596›Full record

Trial reportProstaglandins, leukotrienes, and essential fatty acids2013

Effects of low-dose aspirin and fish oil on platelet function and NF-kappaB in adults with diabetes mellitus.

Robert C Block, Amir Abdolahi, Brian Smith, N Meednu, Kelly Thevenet-Morrison, Xueya Cai, Huadong Cui, Shaker Mousa, J Thomas Brenna, S Georas

Abstract readClinical Trial
In one paragraph

Trial report in Prostaglandins, leukotrienes, and essential fatty acids, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.6field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 17 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Trial
  5. Review
  6. Article
  7. Role of NF-κB in Platelet Function.International journal of molecular sciences · 2019
    Review
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Robert C BlockDepartment of Public Health Sciences, The University of Rochester School of Medicine and Dentistry, Rochester, New York, USA. robert_block@urmc.rochester.edu
Amir Abdolahi
Brian Smith
N Meednu
Kelly Thevenet-Morrison
Xueya Cai
Huadong Cui
Shaker Mousa
J Thomas Brenna
S Georas
University of Rochester · USAlbany College of Pharmacy and Health Sciences · USCornell University · US

Funding

VISUAL INDICES OF NEUROTOXICITYP30ES001247 · NIEHS · UNIVERSITY OF ROCHESTER · PI B Paige Lawrence · 1985 to 2026
$42.8M
UNIVERSITY OF ROCHESTER'S RESEARCH ASSOCIATE ORGANIZATIONUL1RR024160 · NCRR · UNIVERSITY OF ROCHESTER · PI PEARSON, THOMAS ARTHUR · 2006 to 2011
$38.7M
RESEARCH TRAINING IN PREVENTIVE CARDIOLOGYT32HL007937 · NHLBI · UNIVERSITY OF ROCHESTER · PI LOWENSTEIN, CHARLES J · 2000 to 2014
$7.1M
The University of Rochester's Clinical and Translational Science InstituteKL2RR024136 · NCRR · UNIVERSITY OF ROCHESTER · PI PEARSON, THOMAS ARTHUR · 2006 to 2011
$4.3M
LPA and Edg Receptors in the Pulmonary Immune ResposeR01HL071933 · NHLBI · UNIVERSITY OF ROCHESTER · PI GEORAS, STEVE N · 2004 to 2013
$3.1M
Molecular mechanism of omega-3 responseR01AT007003 · NCCIH · UNIVERSITY OF TEXAS AT AUSTIN · PI BRENNA, JAMES T. · 2013 to 2017
$1.9M
The Effects of Fish Oil and Aspirin on Cardiovascular Risk in Type 2 DiabetesR21HL102582 · NHLBI · UNIVERSITY OF ROCHESTER · PI BLOCK, ROBERT CHARLES · 2010 to 2011
$420k
NCCIH NIH HHS 1R01AT007003-01NCCIH NIH HHS R01 AT007003NCRR NIH HHS KL2 RR024136NCRR NIH HHS KL2RR024136NCRR NIH HHS UL1 RR024160NHLBI NIH HHS 5R21HL102582-02NHLBI NIH HHS R01 HL071933NHLBI NIH HHS R01HL071933NHLBI NIH HHS R21 HL102582NHLBI NIH HHS T32 HL007937NHLBI NIH HHS T32HL007937NIEHS NIH HHS P30 ES001247NIEHS NIH HHS P30ES001247
6 · The paper itself

Abstract

introductionMany diabetics are insensitive to aspirin's platelet anti-aggregation effects. The possible modulating effects of co-administration of aspirin and fish oil in subjects with diabetes are poorly characterized. PARTICIPANTS AND

methodsThirty adults with type 2 diabetes mellitus were treated with aspirin 81 mg/d for 7 days, then with fish oil 4 g/day for 28 days, then the combination of fish oil and aspirin for another 7 days.

resultsAspirin alone and in combination with fish oil reduced platelet aggregation in most participants. Five of 7 participants classified as aspirin insensitive 1 week after daily aspirin ingestion were sensitive after the combination. Although some platelet aggregation measures correlated positively after aspirin and fish oil ingestion alone and (in combination) in all individuals, correlation was only observed in those who were aspirin insensitive after ingestion of the combination.

conclusionsCo-administration of aspirin and fish oil may reduce platelet aggregation more than aspirin alone in adults with diabetes mellitus.

Indexed as

AdultAgedAged, 80 and overAspirinDiabetes Mellitus, Type 2FemaleFish OilsHumansMaleMiddle AgedNF-kappa BPlatelet AggregationPlatelet Function TestsAspirinFish OilsNF-kappa B

Identifiers

PMID23664596
PMCPMC3683095
OpenAlexW2072368523

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.